Filing Details
- Accession Number:
- 0001493152-21-020989
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-23 15:42:45
- Reporting Period:
- 2021-08-19
- Accepted Time:
- 2021-08-23 15:42:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1349929 | Vyant Bio Inc. | VYNT | Services-Medical Laboratories (8071) | 043462475 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1850324 | R. Paul Hansen | C/O Vyant Bio, Inc. 2370 State Route 70, Suite 310 Cherry Hill NJ 08002 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.0001 Par Value | Acquisiton | 2021-08-19 | 20,000 | $2.35 | 617,957 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.0001 Par Value | 64,901 | Indirect | By Trust |